// App-Quantinova.ai

Sa1008 : EARLY USE OF THERAPEUTIC DRUG MONITORING TO INDIVIDUALIZE INFLIXIMAB THERAPY IN PAEDIATRIC IBD: A MULTICENTRE PROSPECTIVE COHORT STUDY

Researchers

Presenter

  • Nicholas Carman

Principal Investigators

  • Valerie Arpino

  • Jennifer de Bruyn

  • Wael El-Matary

  • Anthony Otley

  • Hien q. Huynh

  • Peter Church

  • Thomas D. Walters

  • Anne M. Griffiths

  • Karen Frost

  • Amanda Ricciuto

  • Mary Sherlock

  • Jeffrey Critch

  • David R. Mack

  • Eric Benchimol

  • Kevan Jacobson

  • Sally Lawrence

Medical Centers

  • University of Calgary, Calgary, AB, Canada

  • Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, Toronto, ON, Canada

  • Division of Gastroenterology, McMaster Childrens Hospital, West Hamilton, Ontario, Canada

  • B.C. Children's Hospital,, Vancouver, British Columbia, Canada

  • The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • Unversity of Manitoba, Manitoba, Ontario, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • University of Alberta, Edmonton, AB, Canada

  • Memorial University, Newfoundland, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved